Streetbeat News

Analyst Ratings

JFWD

PTEC

Z

Zillow Group, Inc. (NASDAQ:Z) shares rose after Wedbush upgraded the stock from Neutral to Outperform, raising the price target from $50 to $80. Analyst Jay McCanless predicts strong growth due to potential lower mortgage rates, with increased revenue estimates for FY25. Investors can also gain exposure through Global X PropTech ETF (NASDAQ:PTEC) and Jacob Forward ETF (NYSE:JFWD).

Portfolio Pulse from Lekha Gupta

September 16, 2024 | 7:03 pm

MANH

In the past three months, analysts have shown a bullish sentiment towards Manhattan Associates (NASDAQ:MANH), with recent price target increases. The company's strong financial health, including high revenue growth and profitability, supports this positive outlook.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:01 pm

BSY

Bentley Systems (NASDAQ:BSY) has been evaluated by 5 analysts over the past three months, with ratings ranging from bullish to indifferent. The average 12-month price target is $59.6, a slight decline from previous estimates. Analysts have maintained or adjusted their ratings, reflecting their views on Bentley's market position and financial performance. Bentley Systems shows strong net margin and ROE but has a higher debt-to-equity ratio than industry averages.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:01 pm

CUZ

Analysts have varied opinions on Cousins Properties (NYSE:CUZ), with recent ratings showing a mix of bullish and indifferent sentiments. The average 12-month price target has increased to $30.17, indicating positive expectations. The company's financials show strong revenue growth and net margin, but challenges in ROE.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:01 pm

MRK

Analysts have mixed views on Merck & Co (NYSE:MRK) with recent evaluations showing a mix of bullish and bearish perspectives. The average 12-month price target has decreased by 2.29% to $144.12. Merck's financials show strong profitability and effective cost management, with a net margin of 33.86% and a ROE of 13.0%.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:00 pm

RNA

Avidity Biosciences (NASDAQ:RNA) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target has increased to $68.86. Despite challenges like a decline in revenue and low net margins, the company shows strong ROE and low debt dependency.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:00 pm

HAS

In the past three months, five analysts have provided ratings on Hasbro (NASDAQ:HAS), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased by 2.4% to $76.8. Analysts have raised their price targets, reflecting a positive outlook despite Hasbro's recent revenue decline.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 7:00 pm

FDX

Whales are showing a bearish stance on FedEx (NYSE:FDX) with 57% of options trades being bearish. The stock is currently trading at $292.52, up 2.14%, and analysts have set an average target price of $336.33. The anticipated earnings release is in 3 days.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 6:45 pm

DKNG

PENN

DraftKings and other sportsbooks could benefit from favorable outcomes in the second week of the NFL season, with underdogs winning over 50% of games. Needham analyst Bernie McTernan reiterated a Buy rating and $60 price target for DraftKings, highlighting its strong position in the growing North American online gambling market.

Portfolio Pulse from Chris Katje

September 16, 2024 | 6:39 pm

MEOH

UBS analyst Joshua Spector maintains a Buy rating on Methanex (NASDAQ:MEOH) but lowers the price target from $58 to $54.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 6:18 pm